INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions incl...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
07.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. |
---|---|
AbstractList | The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention. |
Author | KIM, Dooseop PIO, Barbara JIANG, Jinlong DING, Fa-Xiang WALSH, Shawn, P GUO, Yan CHOBANIAN, Harry DONG, Shuzhi |
Author_xml | – fullname: DING, Fa-Xiang – fullname: DONG, Shuzhi – fullname: JIANG, Jinlong – fullname: PIO, Barbara – fullname: CHOBANIAN, Harry – fullname: WALSH, Shawn, P – fullname: KIM, Dooseop – fullname: GUO, Yan |
BookMark | eNrjYmDJy89L5WSw9PTz8HTyDPEPClbwd1MI8XBVCHL1c_RR8A8NcQ1S8HV1CfXxcQyKVAjwD3EMDvYM9VVw9nD083P14WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxgYWxqbmxk6GxkQoAQBPYCpB |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITEURS DU CANAL POTASSIQUE MÉDULLAIRE EXTERNE RÉNAL INHIBITOREN DES RENALEN KALIUMKANALS DER ÄUSSEREN MEDULLA |
ExternalDocumentID | EP3083573B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3083573B13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 16 05:52:42 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3083573B13 |
Notes | Application Number: EP20140870698 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240807&DB=EPODOC&CC=EP&NR=3083573B1 |
ParticipantIDs | epo_espacenet_EP3083573B1 |
PublicationCentury | 2000 |
PublicationDate | 20240807 |
PublicationDateYYYYMMDD | 2024-08-07 |
PublicationDate_xml | – month: 08 year: 2024 text: 20240807 day: 07 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | Merck Sharp & Dohme LLC |
RelatedCompanies_xml | – name: Merck Sharp & Dohme LLC |
Score | 3.5538616 |
Snippet | The present invention provides compounds of Formula (I) (Formula (I)) including pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240807&DB=EPODOC&locale=&CC=EP&NR=3083573B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-2IPkVmweNskhSB4bEsmLmEg9lTTJQi9psRH_vrMhrV70NuzCMjsws9-3OzML8IAonlWSWCBNXSoThUtFyZC4FkxV5Qohhcxrh8No5uXKy_xpPoDVrham6xP61TVHRI8q0d_bLl5vfi6xnC63cvu4XOHQ-tnNDEfo2THv1zVVBccyaBI7sS3YNkpClBoyhxqqbCFROkAUrXJnoG8WL0rZ_D5R3FM4THCxpj2DQd2M4Njefbw2gqOwf-9GsXe97TnofuT5lp_F6SuJXZJ5lKQ0MgMS54hISUidPAjM9J0kcWZiiMxDYntmFNHgAohLM9uboA6L_X4XNNlrK1_CsFk39RUQZL0zUauYXiAj0yRFK5muVHJVixqTpHI6hvGfy1z_M3cDJ9xwXVKbegvD9uOzvsODtl3edyb6Bj71fN4 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J97kFyKzaPNumhSB4bEk02ISZSTyHNA3pJi434950NbfWit2EXltmBmf2-3ZlZgAdE8VUhiRnS1IUyVLiU5RUS16xSVblASCHz2mGfTZxEeZ6P5x1Y7mph2j6hX21zRPSoHP29aeP1-ucSy2pzKzePiyUOrZ7seGYJW3bM-3WNVMEyZjQMrMAUTBMlgUUzmUMNVTaQKB0gwla5M9A3gxelrH-fKPYJHIa4WN2cQqes-9Azdx-v9eHI3753o7h1vc0ZTF3muIYbB9ErCWwSO5RElOkeCRJEpMSnVuJ5evROwiDWMUQmPjEdnTHqnQOxaWw6Q9Qh3e83peFeW_kCuvWqLi-BIOudiFpRTTNkZJqkaHk1VQq5KEWtkqR8NIDBn8tc_TN3Dz0n9r3Uc9nLNRxzI7YJbuoNdJuPz_IWD91mcdea6xtFLH_R |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INHIBITORS+OF+THE+RENAL+OUTER+MEDULLARY+POTASSIUM+CHANNEL&rft.inventor=DING%2C+Fa-Xiang&rft.inventor=DONG%2C+Shuzhi&rft.inventor=JIANG%2C+Jinlong&rft.inventor=PIO%2C+Barbara&rft.inventor=CHOBANIAN%2C+Harry&rft.inventor=WALSH%2C+Shawn%2C+P&rft.inventor=KIM%2C+Dooseop&rft.inventor=GUO%2C+Yan&rft.date=2024-08-07&rft.externalDBID=B1&rft.externalDocID=EP3083573B1 |